TANG CAPITAL PARTNERS LP
CIK 1191935 · last filed 2024-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.93M
Companies
15
Total Filings
74
Lifetime Open-Market Net
$232.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Singular Genomics Systems, Inc. (OMIC) Delisted | 10%+ Owner | 340,000 | $20.01 | $6.80M | $5.42M | 1 | 2024-09-18 |
| RAIN | 10%+ Owner | 3,850,513 | $2.04 | $7.86M | $3.69M | 3 | 2023-12-18 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | 10%+ Owner | 4,299,852 | $1.48 | $6.36M | $491.3K | 1 | 2023-05-10 |
| Jounce Therapeutics, Inc. (JNCE) Delisted | 10%+ Owner | 5,279,801 | $1.88 | $9.93M | $257.9K | 1 | 2023-03-14 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | 10%+ Owner | 9,849,224 | $6.22 | $61.26M | $129.62M | 11 | 2021-12-01 |
| APVO | 10%+ Owner | 360,000 | $4.78 | $1.72M | $23.94M | 3 | 2021-11-26 |
| Odonate Therapeutics, Inc. (ODT) Delisted | 10%+ Owner | 15,238,782 | $1.12 | $17.07M | $16.61M | 5 | 2020-09-30 |
| HRTX | 10%+ Owner | 8,532,156 | $0.40 | $3.41M | $33.28M | 3 | 2018-04-02 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 1,238,543 | $58.70 | $72.70M | $1.19M | 2 | 2013-10-28 |
| HERON THERAPEUTICS, INC. /DE/ (APPA) Delisted | Director | 10,575,347 | — | — | $2.50M | 3 | 2010-05-26 |
| VNDA | 10%+ Owner | 2,715,852 | $5.87 | $15.94M | -$3.42M | 7 | 2010-01-19 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | 10%+ Owner | 6,040,136 | — | — | $12.95M | 7 | 2009-03-10 |
| NEOSE TECHNOLOGIES INC (NTEC) Delisted | 10%+ Owner | 0 | $9.63 | $0 | $520.7K | 8 | 2008-11-12 |
| ARADIGM CORP (ARDM) Delisted | 10%+ Owner | 540,000 | — | — | $51.2K | 3 | 2008-10-23 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | 10%+ Owner | 211,383 | — | — | $5.22M | 3 | 2008-05-16 |
Recent Filings · Page 2 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-06 | APVO | Buy (P) | +4,310,025 | $74.55M | EDGAR |
| 2020-09-30 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +554,410 | $7.28M | EDGAR |
| 2020-02-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +509,310 | $3.44M | EDGAR |
| 2020-01-13 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +8,915,046 | $52.30M | EDGAR |
| 2018-12-13 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +100,000 | $1.56M | EDGAR |
| 2018-10-01 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +160,000 | $3.07M | EDGAR |
| 2018-09-26 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +160,000 | $3.16M | EDGAR |
| 2018-04-02 | HRTX | Buy (P) | +576,924 | $15.00M | EDGAR |
| 2018-03-02 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +56,200 | $1.54M | EDGAR |
| 2018-02-27 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +450,000 | $14.32M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.